Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Managing obesity with pharmacotherapy

Diabetes, Metabolic Syndrome and Obesity

ISSN: 1178-7007


Journal Articles:

Managing obesity with pharmacotherapy

Obesity is a chronic, relapsing, progressive disease causing or negatively impacting numerous medical conditions, including diabetes mellitus, cardiovascular disease, and some types of cancer. The foundation of its treatment is lifestyle modification. However, for many people with obesity, these changes are difficult to achieve and to maintain long-term. For this reason, great efforts have been made to develop effective drugs weight-reducing drugs. In the past, pharmacotherapy for obesity produced discouragingly modest weight loss on the whole, and several drugs had to be withdrawn from the market due to unacceptably severe side effects. However, the future of obesity pharmacotherapy looks promising. This Article Collection gathers studies in the area of pharmacological treatment of obesity, including preclinical studies, clinical trials, and reviews.

DR10627, a Novel Dual Glucagon‑like Peptide‑1 and Gastric Inhibitory Polypeptide Receptor Agonist for the Treatment of Obesity and Type 2 Diabetes Mellitus

Shao Y, Chen Y, Zhu M, Liu Y, Fang C, Wang M, Sun P, Fu W, Huang J, Sheng S, Huang Y

Diabetes, Metabolic Syndrome and Obesity 2024, 17:1563-1573

Published Date: 6 April 2024

Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Patients with Overweight/Obesity

She D, Xu W, Liu J, Zhang Z, Fang P, Li R, Kong D, Xuan M, Liu Q, Pan MY, Wang Y, Xue Y

Diabetes, Metabolic Syndrome and Obesity 2023, 16:3007-3017

Published Date: 28 September 2023